Pfizer says it plans to give the data to U.S. regulators later this week. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
The Food and Drug Administration has begun evaluating data from rival Moderna, which hopes to begin offering two kid-sized shots by summer. Preliminary data suggested the three-dose series is 80% effective in preventing symptomatic COVID-19, the companies said, but they cautioned the calculation is based on just 10 cases diagnosed among study participants by the end of April. The study rules state that at least 21 cases are needed to formally determine effectiveness, and Pfizer promised an update as soon as more data is available.
"The study suggests that a low, 3-microgram dose of our vaccine, carefully selected based on tolerability data, provides young children with a high level of protection against the recent COVID-19 strains," he said in a statement.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Covid-19: An end to two years of statistics and BBC whiteboardsNorthern Ireland's Department of Health has published its last Covid-19 daily online update.
Consulte Mais informação »
COVID-19, shootings: Is mass death now tolerated in America?After mass shootings killed and wounded people grocery shopping, going to church and simply living their lives, the nation marked a milestone of 1 million deaths from COVID-19
Consulte Mais informação »
Monkeypox threat doesn't rise to level of COVID-19, President Biden saysSpeaking in Tokyo a day after he said the virus was something 'to be concerned about,' Biden said, 'I just don't think it rises to the level of the kind of concern that existed with COVID-19.'
Consulte Mais informação »
Monkeypox threat doesn't rise to level of COVID-19, President Biden saysSpeaking in Tokyo a day after he said the virus was something 'to be concerned about,' Biden said, 'I just don't think it rises to the level of the kind of concern that existed with COVID-19.'
Consulte Mais informação »
As COVID-19 cases rise, 60% of eligible kids in Illinois are still unvaccinatedDoctors, public health experts and community members who work on vaccine outreach say they hear a range of concerns from parents.
Consulte Mais informação »